Chemoinformaics analysis of Cyclopentylaldehyde-Derivative
Molecular Weight | 112.172 | nRot | 2 |
Heavy Atom Molecular Weight | 100.076 | nRig | 6 |
Exact Molecular Weight | 112.089 | nRing | 1 |
Solubility: LogS | -1.426 | nHRing | 0 |
Solubility: LogP | 1.559 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 20.4935 |
nHD | 0 | BPOL | 12.9065 |
QED | 0.497 |
Synth | 2.325 |
Natural Product Likeliness | 1.581 |
NR-PPAR-gamma | 0.028 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.015 |
Pgp-sub | 0.003 |
HIA | 0.003 |
CACO-2 | -4.451 |
MDCK | 0.0000265 |
BBB | 0.992 |
PPB | 0.287298 |
VDSS | 1.157 |
FU | 0.667742 |
CYP1A2-inh | 0.459 |
CYP1A2-sub | 0.644 |
CYP2c19-inh | 0.111 |
CYP2c19-sub | 0.284 |
CYP2c9-inh | 0.048 |
CYP2c9-sub | 0.637 |
CYP2d6-inh | 0.128 |
CYP2d6-sub | 0.436 |
CYP3a4-inh | 0.076 |
CYP3a4-sub | 0.171 |
CL | 7.126 |
T12 | 0.529 |
hERG | 0.068 |
Ames | 0.199 |
ROA | 0.016 |
SkinSen | 0.957 |
Carcinogencity | 0.5 |
EI | 0.993 |
Respiratory | 0.964 |
NR-Aromatase | 0.018 |
Antiviral | No |
Prediction | 0.952857 |